At a glance
- Originator Daiichi Pharmaceutical
- Class Antivirals; Fluoroquinolones; Small molecules
- Mechanism of Action HIV replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections; Herpes simplex virus infections; HIV infections
Most Recent Events
- 28 Dec 2000 Discontinued-Preclinical for Cytomegalovirus infections in Japan (Unknown route)
- 28 Dec 2000 Discontinued-Preclinical for Herpes simplex virus infections in Japan (Unknown route)
- 28 Dec 2000 Discontinued-Preclinical for HIV infections treatment in Japan (Unknown route)